Mar 6, 2024 9:46 am EST bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
Feb 6, 2024 8:00 am EST Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice
Jan 23, 2024 8:00 am EST bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
Dec 5, 2023 8:00 am EST bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
Nov 30, 2023 8:00 am EST CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
Nov 28, 2023 8:00 am EST bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
